Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Nobel Laureate in Economics and Professor of Economics Paul Krugman Talks SCOTUS
07:09

California Attorney General Rob Bonta Talks Tariff Ruling
06:31

Middle East Geoeconomics Lead for Bloomberg Economics, Dina Esfandiary, Talks US Military, Middle East Tensions
07:38